alexa Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital.
Infectious Diseases

Infectious Diseases

Journal of AIDS & Clinical Research

Author(s): Mzileni MO, LongoMbenza B, Chephe TJ, Mzileni MO, LongoMbenza B, Chephe TJ

Abstract Share this page

Abstract INTRODUCTION: Since the initiation of regular antiretroviral therapy and highly active antiretroviral therapy (HAART) in South Africa in 2004, data on effects of HAART on mortality are not available in our hospital. OBJECTIVES: We sought to describe mortality trends and causes of deaths among HIV-infected patients in the HAART era. PATIENTS AND METHODS: Consecutive HIV-infected adults who were prescribed HAART in our hospital were prospectively followed-up from July 2004 to December 2006 or until death, loss to follow-up, discontinuation of HAART or referral to another center. RESULTS: Out of 2605 HIV-infected patients analyzed at the end of 2006, 7.8\% (n = 205) died. The causes of these 205 deaths were dominated by AIDS related disorders such as opportunistic infection (47.6\%) and advanced AIDS status (37.3\%). Non-AIDS infectious diseases, liver diseases, cardiovascular diseases, and cancers were rare. Mortality rate was higher in males (28\%, p < 0.0001) than females (8\%) as well as in subgroup with CD4 cell counts < 200/microl (8\%, p < 0.0001) than in subgroup with CD4 cell counts > 200/microl (4.9\%). There was a negative significant dose - response relationship (p for linear trend < 0.0001) between mortality and baseline CD4 cell counts among patients with CD4 cell counts < 200/microl, 13\% in the CD4 < 50/microl group, 6\% in the CD4 51-100/microl group, 5.5\% in the CD4101-150/microl group, and 3\% in the CD4 > 151/microl group. Mortality was not associated with age and HAART regimens. CONCLUSIONS: Prevention of AIDS-defining conditions and expansion of earlier access to HAART could substantially reduce mortality in resource-poor settings.
This article was published in Pol Arch Med Wewn and referenced in Journal of AIDS & Clinical Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords